Elantas Beck India Ltd

The Sensex advanced 0.81% on 29 Apr 2026, yet Elantas Beck India Ltd outpaced the broader market with a 7.03% gain, touching an intraday high of Rs 10,190. This 5.73 percentage-point outperformance over the Specialty Chemicals sector highlights a distinctly stock-specific rally rather than a market-wide lift.

Elantas Beck India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Elantas Beck India Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in price momentum and technical indicators, reflecting a complex market stance as of early April 2026. Despite a strong day gain of 6.28%, the stock’s technical parameters reveal a nuanced picture with mixed signals across weekly and monthly charts, prompting a reassessment of its near-term outlook.

Elantas Beck India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 April 2026, providing investors with an up-to-date perspective on the company's performance and outlook.

The Sensex declined by 2.09% on 1 Apr 2026, while Elantas Beck India Ltd surged 7.27%, outperforming its Specialty Chemicals sector by 3.76 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market environment.

Elantas Beck India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the company's current position as of 28 March 2026, providing investors with an up-to-date view of the stock's fundamentals, returns, and technical outlook.

A sharp decline has pushed Elantas Beck India Ltd to a fresh 52-week low of Rs 7111 on 23 Mar 2026, marking a significant 50.1% drop from its peak of Rs 14,250 within the last year. This downturn comes amid a broader market sell-off, but the stock’s underperformance is notably more severe than the benchmark indices.

Elantas Beck India Ltd, a player in the Specialty Chemicals sector, touched a new 52-week low of Rs.7301.1 today, marking a significant decline in its stock price amid broader market dynamics and company-specific valuation concerns.

Elantas Beck India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 17 March 2026, providing investors with an up-to-date view of its performance and outlook.

Elantas Beck India Ltd’s stock declined sharply to a new 52-week low of Rs.7400 on 16 Mar 2026, marking a significant drop amid broader market movements and sectoral underperformance. The stock’s recent slide reflects a continuation of downward momentum, with multiple technical and fundamental factors contributing to the current valuation.

Elantas Beck India Ltd recorded a robust intraday performance on 10 Mar 2026, surging 8.9% to touch a day’s high of Rs 8,130, marking a significant rebound after six consecutive days of decline and outperforming its sector by 3.71%.

Elantas Beck India Ltd’s share price declined sharply to a new 52-week low of Rs.7599.95 on 9 March 2026, marking a significant downturn amid broader market weakness and sectoral pressures. The stock has underperformed both its sector and the wider market, reflecting a challenging period for the specialty chemicals company.

Elantas Beck India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Elantas Beck India Ltd, a key player in the specialty chemicals sector, has recently experienced a notable shift in its technical momentum, signalling a bearish trend. Despite a strong long-term performance relative to the Sensex, recent technical indicators suggest caution for investors as the stock price declined by 2.24% on 2 Mar 2026, closing at ₹8,962.05.

Elantas Beck India Ltd, a key player in the specialty chemicals sector, has experienced a subtle shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest day gain of 0.83%, the stock’s technical indicators reveal a nuanced picture that investors should carefully analyse amid evolving market conditions.

Elantas Beck India Ltd, a key player in the specialty chemicals sector, has experienced a notable shift in its technical momentum, with recent indicators signalling a bearish trend. The company’s stock price has declined by 1.27% to ₹8,900.10, reflecting growing investor caution amid mixed technical signals and a downgrade in its Mojo Grade from Hold to Sell as of 1 September 2025.

Elantas Beck India Ltd., a leading specialty chemicals manufacturer for electrical insulation and construction industries, reported a marginal sequential decline in Q3 FY26 results, with net profit standing at ₹39.37 crores compared to ₹36.26 crores in Q2 FY26, marking an 8.58% quarter-on-quarter increase. However, the company's stock has remained under pressure, trading at ₹9,220.00 with a market capitalisation of ₹7,254 crores, reflecting investor concerns over its premium valuation of 52x trailing earnings against an industry average of just 13x.